Jenny F. Seligmann

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Andrés Cervantes, R. Adam, Susana Roselló et al. · Annals of Oncology · 2022 · 1.4K citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +7

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

Dion Morton, Laura Magill, Kelly Handley et al. · Journal of Clinical Oncology · 2023 · 387 citations · Full text

Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

Jenny F. Seligmann, David J. Fisher, Christopher G. Smith et al. · Annals of Oncology · 2016 · 163 citations · Full text

Medicine, Cancer Management, Randomised Clinical Trials +6

Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With<i>RAS</i>Wild-Type Advanced Colorectal Cancer

Jenny F. Seligmann, Faye Elliott, Susan D. Richman et al. · JAMA Oncology · 2016 · 105 citations · Full text

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): a phase 2–3 randomised trial

Richard Adams, Ewan Brown, Louise Brown et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 55 citations · Full text